Germany – Health services – Gutachten zur Umsetzung und zu den Folgen der Kassenzulassung des nicht invasiven Pränataltests (NIPT) auf Trisomien
Germany – Health services – Opinion on the implementation and consequences of the cash approval of the non-invasive prenatal test (NIPT) for trisomiesEnglish, machine translated
Issued by Bundesministerium für Gesundheit · via TED — Tenders Electronic Daily (EU)
- Published
- 18 Nov 2026
- Closes
- 17 Dec 2026, 23:59 UTC
- Reference
- 800206-2026
- Location
- Germany
- Sector
- Healthcare & Pharma
- Type
- services
At a glance
Bundesministerium für Gesundheit in Germany has published an invitation to bid in healthcare & pharma: “Germany – Health services – Gutachten zur Umsetzung und zu den Folgen der Kassenzulassung des nicht invasiven Pränataltests (NIPT) auf Trisomien”. Submissions close on 17 December 2026, 30 days from today. Quote reference 800206-2026 in any correspondence with the buyer. One document is attached to this notice. FreeTender has recorded 13 notices from this buyer since 2026, 7 of them currently open. There are 883 open healthcare & pharma notices in Germany on FreeTender. Bids are submitted to the buyer through TED — Tenders Electronic Daily (EU), not through FreeTender.
Key requirements
Taken from the notice by FreeTender. The tender document on the official portal is binding — check it, and any corrigendum, before you bid.
To bid on EU public procurement
Most EU buyers ask for the European Single Procurement Document (ESPD) as a self-declaration with the bid. Submission is on the e-procurement platform named in the notice.
English summary
Machine translated from German by FreeTender. The original notice below is the binding text.
An expert opinion will be issued which will present in a report form the facts with regard to the application of the non-invasive prenatal test (NIPT) on trisomies in Germany in a generally understandable manner, taking into account the available data. Lots Lot 1 — Opinion on the implementation and consequences of the cash admission of the non-invasive prenatal test (NIPT) on trisomies Buyer: Federal Ministry of Health Location: Bonn Buyer country: DEU Procedure: open CPV code: 85100000 Full notice, tender documents and how to bid are on the official TED page (link above).
Details
Es soll ein Gutachten vergeben werden, das in Berichtsform den Sachverhalt in Bezug auf die Anwendung des nicht invasiven Pränataltests (NIPT) auf Trisomien in Deutschland unter Einbeziehung der vorhandenen Daten allgemein verständlich darstellt.
Lots Lot 1 — Gutachten zur Umsetzung und zu den Folgen der Kassenzulassung des nicht invasiven Pränataltests (NIPT) auf Trisomien
Buyer: Bundesministerium für Gesundheit
Buyer country: DEU
Procedure: open
CPV code: 85100000
Full notice, tender documents and how to bid are on the official TED page (link above).
Context for bidders
We hold 13 notices from Bundesministerium für Gesundheit, going back to August 2026 — 7 of them still open. They buy mostly in Healthcare & Pharma, IT & Telecom and Financial & Professional Services. There are 883 open Healthcare & Pharma tenders in Germany. This one closes in 30 days.
More from this buyer
- Germany – Health services – Betriebsführung zur Abwicklung der Beschaffungsprozesse im Zusammenhang mkit der COVID-19-Pandemie· closes 19 Nov
- Betriebsführung zur Abwicklung der Beschaffungsprozesse im Zusammenhang mit der COVID-19-Pandemie· closes 19 Nov
- Gutachten zur Umsetzung und zu den Folgen der Kassenzulassung des nicht invasiven Pränataltests (NIPT) auf Trisomien· closes 17 Dec
- Germany – Health services – Gutachten zur Umsetzung und zu den Folgen der Kassenzulassung des nicht invasiven Pränataltests (NIPT) auf Trisomien· closes 17 Dec
- Förderung von multidisziplinären transnationalen Forschungsvorhaben zum Thema: „Zell- und Gentherapie für die personalisierte Medizin“ (CGT4PM2027) innerhalb der Europäischen Partnerschaft für Personalisierte Medizin (EP PerMed)“· closes 20 Jan
Similar Healthcare & Pharma tenders
- Germany – Pharmaceutical products – Open House Biologika Rabattverträge 2026-24 - Aflibercept (ATC: S01LA05; Wirkstärke: 40 mg/ml)· closes 31 Dec
- Open House Biologika Rabattverträge 2026-24 - Aflibercept (ATC: S01LA05; Wirkstärke: 40 mg/ml)· closes 31 Dec
- Germany – Pharmaceutical products – Open House Biologika Rabattverträge 2026 - 12 Epoetin alfa und Epoetin zeta· closes 31 Dec
- Open-House-Biologika-Rabattverträge 2026-05 - Pegfilgrastim· closes 30 Apr
- Germany – Pharmaceutical products – Open-House-Biologika-Rabattverträge 2026-05 - Pegfilgrastim· closes 30 Apr
Explore Germany
Documents
- TED-official-notice-800206-2026.pdfDownload (pdf)
Before you bid on this tender
A quick checklist to help you decide whether to bid and prepare a compliant submission for this healthcare & pharma opportunity. Always verify the details on the official source.
- Confirm the exact closing date and time (and time zone) on the official portal — deadlines are strict and can be revised by a corrigendum.
- Read the full notice and every attached document, including the scope, specifications and any bill of quantities or terms of reference.
- Check the eligibility criteria — prior similar experience, annual turnover, certifications and registrations — and make sure you qualify before investing effort.
- Prepare any earnest-money deposit (EMD) or bid security and the required formats early; missing or wrongly-formatted documents are a common cause of rejection.
- Note how bids must be submitted (online or physical), in what format, and whether a digital signature or portal registration is required.
- Watch for corrigenda and clarifications right up to the deadline — requirements and dates can change.
Who won similar contracts
Recent contract awards in Germany, from published award notices.
- Suivi et Contrôle des travaux d'alimentation en eau potable d'Issia et localités environnantesWon by GOPA - International Energy Consultants GmbH (Allemagne) · XOF 151,478,080.00 · 30 Sept 2026
- Supervision of works for Viroi bridgeWon by Schneider & Partner Ingenieur-consult GMBH (Germany) · EUR 140,000.00 · 18 Aug 2026
More Healthcare & Pharma tenders
- Поставка лекарственного препарата для медицинского применения МНН ДАПАГЛИФЛОЗИНФЕДЕРАЛЬНОЕ ГОСУДАРСТВЕННОЕ БЮДЖЕТНОЕ УЧРЕЖДЕНИЕ "ФЕДЕРАЛЬНЫЙ ЦЕНТР МОЗГА И НЕЙРОТЕХНОЛОГИЙ" ФЕДЕРАЛЬНОГО МЕДИКО-БИОЛОГИЧЕСКОГО АГЕНТСТВА · Russia
- Поставка лекарственных препаратов для медицинского примененияФЕДЕРАЛЬНОЕ ГОСУДАРСТВЕННОЕ БЮДЖЕТНОЕ УЧРЕЖДЕНИЕ "ФЕДЕРАЛЬНЫЙ ЦЕНТР МОЗГА И НЕЙРОТЕХНОЛОГИЙ" ФЕДЕРАЛЬНОГО МЕДИКО-БИОЛОГИЧЕСКОГО АГЕНТСТВА · Russia
- Поставка лекарственного препарата (Пиридостигмина бромид (ТН: Калимин 60 Н)) для обеспечения пациента на основании решения врачебной комиссии (УНЗ: Z272309 - Д)ГОСУДАРСТВЕННОЕ КАЗЕННОЕ УЧРЕЖДЕНИЕ ГОРОДА МОСКВЫ "АГЕНТСТВО ПО ЗАКУПКАМ (КОНТРАКТНАЯ СЛУЖБА) ДЕПАРТАМЕНТА ЗДРАВООХРАНЕНИЯ ГОРОДА МОСКВЫ" · Russia
- Поставка лекарственного препарата для медицинского применения МНН НАТРИЯ ХЛОРИДФЕДЕРАЛЬНОЕ ГОСУДАРСТВЕННОЕ БЮДЖЕТНОЕ УЧРЕЖДЕНИЕ "ФЕДЕРАЛЬНЫЙ ЦЕНТР МОЗГА И НЕЙРОТЕХНОЛОГИЙ" ФЕДЕРАЛЬНОГО МЕДИКО-БИОЛОГИЧЕСКОГО АГЕНТСТВА · Russia
- Поставка лекарственных препаратов (ципрофлоксацин) для нужд КГБУЗ "Кежемская РБ"КРАЕВОЕ ГОСУДАРСТВЕННОЕ БЮДЖЕТНОЕ УЧРЕЖДЕНИЕ ЗДРАВООХРАНЕНИЯ "КЕЖЕМСКАЯ РАЙОННАЯ БОЛЬНИЦА" · Russia
FreeTender mirrors this notice for reference. Verify the details and bid on the official portal.
Verify & apply on the official portal →